Rick Simpson Oil (RSO) in San Bernardino County: The Complete Guide by OilWell Cannabis

If you’re reading this in San Bernardino County — whether you’re in San Bernardino proper, Ontario, Rancho Cucamonga, Fontana, or out in the High Desert communities of Apple Valley and Victorville — you’ve likely heard the term “RSO” whispered in cancer support groups, veteran meetups, or chronic pain communities. Maybe you discovered it while researching alternatives after the VA in Loma Linda couldn’t offer more options. Maybe a neighbor mentioned it at a block party in Redlands. Maybe you’re sitting in your car right now, parked outside a dispensary in Upland, trying to figure out what “RSO” actually means before you walk in.

We get it. The Inland Empire’s cannabis landscape can feel overwhelming. Between the legacy of Prop 64, the patchwork of local ordinances, and the sheer volume of products claiming to be “RSO” on dispensary shelves from Chino Hills to Twentynine Palms, you need straight answers grounded in real science — not hype, not myths, and definitely not the snake oil that floods this industry.

We’re OilWell Cannabis. We started in Houston, Texas, not California — and that’s exactly why this guide matters for San Bernardino County. We built our RSO formulas from the ground up using medical-grade precision (Colin, our founder, did custom development work for Baylor College of Medicine), but we also carry the ethos of the original RSO movement: accessibility, transparency, and putting patient control first. We publish our complete formulas publicly. We ship nationwide, which means whether you’re in the shadow of the San Bernardino Mountains or commuting through the Cajon Pass, you can access the same clinical-strength product that doctors in the Texas Medical Center use for Crohn’s, PTSD, and benzo withdrawal.

This is the most comprehensive RSO education resource available for San Bernardino County. We’ll walk you through the real history of Rick Simpson — the man, the myth, the evidence (and what he got right vs. what he overstated). We’ll show you how our formulas differ from traditional RSO in ways that matter for your safety and results. We’ll break down the science of every cannabinoid and terpene we use, with peer-reviewed citations you can verify. And we’ll tell you exactly how to get our products delivered to your door in San Bernardino County — same-day if you’re in Houston’s delivery zone, 2-3 days via USPS Priority if you’re anywhere from Hesperia to Yucaipa.

Let’s start at the beginning. Because if you’re going to put anything in your body — especially if you’re a cancer patient at Kaiser Fontana, a veteran at the Loma Linda VA, or someone tapering off benzos under a doctor’s supervision in Rancho Cucamonga — you deserve to know the full story.

The Real Story of Rick Simpson and Traditional RSO

Who Was Rick Simpson?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor, scientist, or medical researcher. He was a power engineer and maintenance worker — a blue-collar tradesman who got hurt on the job and got angry when the medical system failed him. In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t fix. The medications either didn’t help or made things worse. Cannabis provided more relief than anything his doctors offered, but when he asked his physician to consider it, the request was refused.

Sound familiar? If you’re in San Bernardino County, you might know someone who works construction in the Inland Empire’s booming logistics and warehouse sector — Amazon fulfillment centers in San Bernardino, FedEx hubs in Fontana, manufacturing in Ontario. Workplace injuries happen. Chronic pain follows. Prescriptions get cycled. Doctors say no to cannabis. Simpson’s story resonates because it’s the story of thousands of people in our own backyard.

Simpson’s interest in concentrated cannabis oil deepened after he learned about a 1974 NIH-funded study at the Medical College of Virginia, where THC was reported to slow or shrink tumors in mice. That study — originally intended to demonstrate harm — became a foundational reference point for Simpson. But here’s the critical context: its findings were never replicated in controlled human cancer trials. This is the pattern that defined Simpson’s approach: interesting preclinical signals that he extrapolated far beyond what the evidence could support.

The 2003 Skin Cancer Incident: Where RSO Was Born

The pivotal moment came in 2003. Simpson reported that three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. By his account, the bumps disappeared within four days. No biopsy confirmation, no independent medical verification, no clinical follow-up in any peer-reviewed source. This personal experience became the origin story of Rick Simpson Oil.

Important context: Simpson’s account is his personal testimony, not medical evidence. The absence of clinical documentation means these events cannot be evaluated as scientific proof. But they are historically significant as the catalyst for a global movement. In San Bernardino County, we see this pattern all the time — desperate patients sharing stories in Facebook groups, at support meetings in Redlands, or in whispered conversations at Eisenhower Medical Center in Rancho Mirage. Those stories matter emotionally, but they are not proof.

The Crusade: Free Distribution and Legal Conflict

After 2003, Simpson committed himself to producing and distributing concentrated cannabis oil for free. Operating from his property in Maccan, Nova Scotia, he made oil in large quantities and gave it away to cancer patients and others in his community. He helped people with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia — the same conditions that drive San Bernardino County residents to search “RSO near me” today.

His story went global through the 2005 documentary Run From The Cure, directed by Christian Laurette. The film showed testimonials, framed his work as a grassroots challenge to pharmaceutical interests, and became foundational in cannabis communities. For many people — including many in San Bernardino County who first encountered RSO through online forums or local activists — that documentary was their introduction to concentrated cannabis oil as medicine.

But Simpson’s advocacy brought him into direct conflict with Canadian law. The RCMP raided his property in 2005 and 2009. He was charged with cultivation, possession, and trafficking. Facing continued pressure, he eventually left Canada for Europe, living in Croatia and later the Netherlands. He published Phoenix Tears in 2012 and maintained phoenixtears.ca as his platform.

Throughout his career, Simpson maintained that cannabis oil could cure cancer and that pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge. He framed his work as fighting institutional corruption.

What Simpson got right: He drew attention to cannabinoids as a serious biomedical research area when the world was ignoring it. He helped create the conditions for the legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What he overstated: The leap from preclinical signals to cancer cure was never supported by human evidence. Encouraging patients to rely on RSO as a primary cancer treatment in place of proven therapies carries genuine harm potential. Delayed treatment for treatable cancers is a documented concern in alternative medicine. Simpson’s absolute certainty exceeded what the evidence could support.

The Traditional RSO Protocol: 60 Grams Over 90 Days

Simpson’s core recommendation was a structured oral protocol: 60 grams of concentrated cannabis oil over approximately 90 days. Here’s the breakdown:

• Week 1: Half a grain of rice-sized dose (10-15mg) three times daily
• Weeks 2-5: Double the dose every four days until reaching 1 gram per day
• Weeks 5-12: Maintain 1 gram per day (three 333mg doses) until 60 grams consumed

Administration: Oral/sublingual primarily, topical for skin cancers, inhalation acknowledged for symptom relief but not as primary treatment.

Important context for evaluating this protocol:

• No controlled trial validation exists
• It assumes crude, unstandardized material with unknown potency
• Peak dosing delivers 600-900mg of delta-9 THC daily — far exceeding anything studied clinically
• Real risks at these doses include severe intoxication, anxiety, panic, tachycardia, and cannabis use disorder
• Cancer patients using this instead of proven therapies face genuine harm

This protocol was designed for a product that no longer exists in its original form. Traditional RSO had no standardization — every batch differed based on plant genetics, growing conditions, and extraction technique. The oil was nearly black, thick, tar-like, with possible solvent-residual smell. It was effectively stripped of terpenes by the solvent + heat process. There was no lab testing, no Certificate of Analysis, no contaminant screening.

The residual solvent risk is significant: naphtha (a petroleum-based solvent) and isopropyl alcohol are not food-grade. Naphtha may contain benzene, toluene, and other carcinogens. Incomplete purging leaves harmful residues.

Traditional RSO vs. Modern Formulated RSO

Dimension	Traditional RSO	OilWell RSO
Source material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction	Naphtha or isopropyl alcohol	Food-grade ethanol or CO₂, solvent-free formulation
Cannabinoid profile	THC-dominant, uncontrolled	7 defined cannabinoids at specific ratios
Terpene content	Destroyed by heat	Live terpenes at 5% with defined 7-terpene profile
Standardization	None – every batch different	Lab-tested with specific mg/mL targets (553 mg/mL)
Residual solvents	Significant risk	Controlled and tested – no solvents in finished product
Delta-9 THC exposure	600-900 mg/day at peak	90 mg total in entire bottle (3 mg/mL)
Product formats	Single thick oil only	Sublingual oil and vape cartridge
THCa preservation	No – fully decarboxylated	Yes – 1,500 mg THCa as separate ingredient
Evidence approach	Anecdotal, personal testimony	Research-backed, peer-reviewed citations
Access	Illegal, black market	Farm Bill compliant, ships nationwide

Why OilWell’s Formulas Diverge from Traditional RSO

We made deliberate, evidence-motivated departures from Simpson’s model:

Multi-cannabinoid approach: Traditional RSO used whatever single strain was available. We include seven cannabinoids because the entourage-effect literature suggests potential benefit from diversity, even though robust clinical proof of whole-formula synergy remains limited [20][29]. For San Bernardino County residents dealing with multiple conditions — say, a veteran in Hesperia with PTSD, chronic pain, and insomnia — single-cannabinoid approaches often fall short.

Terpene preservation: Traditional RSO had no terpenes. We include live terpenes at 5% with a specific profile because terpene bioactivity is plausible and supported at preclinical levels, even if human clinical confirmation remains developing [20][21][23][24][25][26][27][28][29].

THCa as separate ingredient: Traditional RSO fully decarboxylated everything. We preserve 1,500 mg THCa because the literature suggests potentially relevant non-psychoactive bioactivity (anti-inflammatory via COX-2, neuroprotective via PPARγ) that is lost when THCa converts to THC [12].

Reduced delta-9 THC dominance: Traditional RSO was 60-90% delta-9 THC. Our sublingual formula uses only 90 mg delta-9 THC total, distributing the remaining 16,500 mg across CBD, CBG, delta-8 THC, THCa, CBN, and CBC. This reflects the broader cannabinoid research landscape rather than single-compound dominance.

Product format innovation: Simpson had one crude format. We offer both sublingual oil (30 mL, 553 mg/mL, 15-45 minute onset, 4-6 hour duration) and vape cartridge (1 gram, 900+ mg, 1-2 minute onset, 2-4 hour duration) because different delivery routes have different pharmacokinetic profiles [14].

Solvent-free production: No naphtha. No isopropyl alcohol. We blend individual cannabinoid distillates in organic MCT oil. Third-party testing covers potency, terpenes, pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis are available on request.

The Decarboxylation Choice: Patient-Controlled Potency

Traditional RSO gave patients no choice about psychoactivity — it was always fully activated. Our sublingual formula puts that control in your hands:

Option 1 – Raw (non-psychoactive): All 1,500 mg stays as THCa. Use it for daytime anti-inflammatory support without impairment. Perfect for San Bernardino County residents who work in the logistics warehouses of Fontana, drive trucks through the Cajon Pass, or operate machinery in the High Desert.

Option 2 – Fully activated: Heat at 260°F (125°C) for 45-60 minutes. This converts 1,500 mg THCa into approximately 1,315 mg delta-9 THC. Combined with the existing 90 mg delta-9 THC and 6,000 mg delta-8 THC, you get full psychoactive potency comparable to traditional illegal RSO — 100% legally, because decarboxylation happens after purchase at your discretion.

Option 3 – Vape (instant activation): The vape cartridge auto-decarboxylates THCa at 400-450°F. Every puff delivers freshly converted delta-9 THC for breakthrough relief.

The conversion ratio: 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation, accounting for the CO₂ molecule lost.

The Origin of OilWell Cannabis: From McAllen to San Bernardino County

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But the story starts in McAllen, Texas — right across the river from Reynosa, Tamaulipas, one of the most dangerous border regions in North America. Colin grew up in that world: violence, friends killed or imprisoned, learning to hustle by transporting items across the border at sixteen. He’s faced every form of violence imaginable, both in the streets and across the border.

Despite those dangers, Colin didn’t fall into selling harder substances. He focused on cannabis, seeing it as a safer alternative. He learned the plant intimately while operating in the shadows, then transitioned to legal business as the laws changed. Later, he became a formally trained software engineer and did custom development work for Baylor College of Medicine — one of the most prestigious medical institutions in the Texas Medical Center. That combination of deep plant knowledge plus medical-grade technical precision defines everything we do.

But the real origin story begins with a dog named Bentley. Bentley was family — a companion who stood by Colin through the toughest times. When Bentley fell seriously ill, veterinarians delivered the verdict every pet owner fears: euthanasia was the only humane option. Bentley was paralyzed in his back legs. Pain meds would destroy his internal organs. The choice was painful decline or mercy killing.

Giving up wasn’t an option. In a desperate search, Colin stumbled upon CBD through a question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?” That blind spot would become his mission.

Colin learned to create CBD golden paste — a specialized cannabinoid formula for pets. It wasn’t a cure, but it was hope. And that hope delivered something veterinary medicine said was impossible: Bentley got up. He walked over to Colin and brought him his ball to play. From paralyzed and facing euthanasia to fetching his ball. This was not placebo effect — dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed formulas for every age-related condition:

• Neurodegeneration → CBG neuroprotection and THCa PPARγ agonism for brain cell protection
• Dementia → CBC’s role in neurogenesis
• Glaucoma → THC’s CB1 agonism for intraocular pressure
• Crippling arthritis → Multi-pathway anti-inflammatory using CBD, CBG, THCa, and beta-caryophyllene through different receptor systems simultaneously

Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy. Pharmaceutical precision mattered — Bentley’s life depended on formula accuracy, not guesswork. That decade of real-world formulation testing on a patient Colin loved more than anything is the foundation of our RSO formula.

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey — notoriously difficult and dangerous — using the cannabinoid knowledge he developed keeping Bentley alive. Our Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form for insomnia and severe PTSD. This is not theoretical knowledge. He lived what RSO patients live.

Over time, doctors began using our formulas for Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. We focus on making cannabis accessible for everyone, including vegans, diabetics, and those with specific health needs.

ABC13: Houston’s Number-One News Source Featured Us Seven Times

Between September 2019 and April 2023, ABC13 Houston featured Colin and OilWell Cannabis in seven comprehensive news segments. Five different reporters sought us out across those years. No other Houston cannabis operator appears with that frequency or breadth.

September 15, 2019 — “Texas CBD businesses booming” (Tom Abrahams)

This was our first ABC13 feature. Colin’s quote from this segment captures our philosophy: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

That quote — from 2019, years before we published our formulas — is the seed of everything we became. The open-source publication, the evidence-based documentation, the refusal to make unsupported claims: it all traces back to this principle.

March 22, 2021 — “Entrepreneur creates direct-to-consumer business ahead of marijuana decriminalization” (Tom Abrahams)

This feature established Colin’s role as an ecosystem builder who helped other entrepreneurs enter the legal cannabis space. His therapy quote — “Pain comes in a lot of different forms” — went deeper than any prior interview.

May 24, 2021 — “What is Delta 8 THC and why is it considered legal weed in Texas” (Steve Campion)

This investigative feature became one of ABC13’s most widely referenced cannabis segments. The exchange between Campion and Colin — “Maybe you want to get high” — became an iconic moment: radical honesty on mainstream television.

August 20, 2021 — “Houston CBD shop giving away free products to those who get COVID vaccine”

We gave away approximately $35,000 in product (1,000 caviar pre-rolls at $34.99 each) to encourage COVID vaccination. We coordinated with the city of Houston. No political strings attached.

October 19, 2021 — “Texas ban over once legal hemp product Delta 8 raises questions over legality” (Shelley Childers)

When Texas DSHS classified Delta-8 as Schedule I overnight, Colin proactively removed all products before enforcement began and tried to warn other operators who were unknowingly shipping Schedule I narcotics. That willingness to absorb a major revenue loss to act ethically — that is our character.

October 7, 2022 — “Biden marijuana pardon — experts weigh in on why Texas won’t see impact” (Nick Natario)

This feature revealed that Colin has personally faced charges for marijuana possession. That personal history transforms our entire media record. Every quote about therapy, education, and not selling snake oil carries additional weight when you understand the person saying it has lived the consequences of cannabis criminalization.

April 21, 2023 — “Marijuana industry getting creative as Texas laws continue to change” (Nick Natario)

The most recent feature positioned us at the frontier. Colin’s “Renaissance” framing reframed the present as opportunity rather than waiting.

Complete Index of Colin’s Quotes Across All ABC13 Features

1. “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.” (Sept 2019)

2. “Pain comes in a lot of different forms.” (March 2021)

3. “I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”* (May 2021)

4. “We just want Houston to be as healthy as possible. We’re not doctors. We’re not experts on this . We don’t have any political agenda. Come and participate if it’s right and safe for you and your loved ones!” (Aug 2021)

5. “[We’re] trying to get the city behind me to help as many people as we can. I really want to help things.” (Aug 2021)

6. “It’s going to be a surprise to a lot of people.” (Oct 2021)

7. “It was a prime seller and a prime interest of customers, and they really enjoyed the benefits of it.” (Oct 2021)

8. “So those people are now, because they didn’t know, shipping Schedule 1 narcotics, and people are receiving it.” (Oct 2021)

9. “It’s disappointing, but I’m not going to lose my customers and business are going to want our expertise on how to continue thriving in the industry.” (Oct 2021)

10. “You face challenges with housing, loans, and banking, I mean with about everything.” (Oct 2022)

11. “I would love to see people not get hurt for this anymore.” (Oct 2022)

12. “I want it to be legalized. I’m just saying that’s a very hyped conversation. If you really look at what’s here now, there’s nothing you could show me that I could accomplish with what literally we have right now.” (April 2023)

13. “Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.” (April 2023)

The Science Behind Every Cannabinoid in Our Formula

Research Method and Evidence Weighting

We prioritize sources in this order: human clinical evidence, systematic reviews, NIH institutional summaries, then preclinical literature when human data are sparse. This matters because the evidence base is not evenly distributed. CBD and delta-9 THC have the strongest human data; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes still rely more on reviews, animal work, and early translational literature [1]-[29].

CBD: The Foundation

CBD has the strongest human evidence in our formula, especially as a purified product rather than loose wellness ingredient [1]-[6].

Best supported: Purified CBD has the most credible human evidence in seizure disorders — the clearest major-example indication acknowledged by institutional literature [1][2].

Anxiety: A 2024 systematic review and meta-analysis covering 316 participants reported a statistically significant anxiolytic signal, but authors stressed the clinical sample remains limited and more trials are needed before broad conclusions [3].

Pain: A 2024 systematic review of CBD monotherapy studies concluded the pain literature is promising but heterogeneous, with trial quality limiting confidence in broad analgesic claims [4].

Sleep: A 2023 insomnia review found the literature methodologically weak, with many studies relying on nonvalidated subjective measures [5].

Safety: A 2023 systematic review found a real signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy settings [6]. NCCIH flags diarrhea, sleepiness, appetite change, mood effects, liver abnormalities, and drug-drug interactions [1].

Bottom line: CBD is the most evidence-developed nonintoxicating cannabinoid, but strong evidence concentrates in specific indications rather than broad wellness claims [1]-[6].

CBG: The Emerging Neuroprotector

CBG evidence is mostly review-level and preclinical; human evidence remains sparse [7][8].

Pharmacology: CBG is the biosynthetic precursor to several major cannabinoids with pharmacologically distinct properties. Review literature describes interactions spanning cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A-related signaling — mechanistically interesting but not yet clinically established [7].

Research areas: Reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity, but these are primarily pharmacology-led hypotheses or preclinical findings rather than mature human therapeutic conclusions [7][8].

Caution: The 2021 pharmacology review notes that CBG is already being sold commercially while the evidence base remains thin, meaning claims frequently outrun the science [7].

Bottom line: CBG is a serious research topic but should be described as a promising minor cannabinoid with limited clinical validation rather than proven therapeutic [7][8].

Delta-8 THC: The THC Analogue

Delta-8 THC is pharmacologically relevant, psychoactive, and much less clinically characterized than delta-9 THC [9]-[11].

Comparative pharmacology: A 2022 review concluded delta-8 and delta-9 THC have broadly similar pharmacokinetic and pharmacodynamic behavior. Delta-8 is a partial CB1 agonist with cannabimimetic activity, but appears less potent than delta-9, likely due to weaker CB1 affinity [9].

Public health: A 2023 scoping review found the delta-8 evidence base dominated by animal studies, product chemistry, use reports, and public-health concerns rather than strong modern human trials. The review noted reports of adverse consequences and emphasized regulatory and product-quality concerns [10].

Manufacturing: A 2024 chemistry review notes commercial delta-8 interest is tied to greater stability and easier synthesis relative to naturally scarce plant levels, which is why product-byproduct and lab-testing questions matter [11].

Bottom line: Delta-8 THC should be treated as a psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, and more manufacturing-quality uncertainty than many consumers realize [9]-[11].

THCa: The Legal Innovation

THCa is important chemically and formulation-wise, but still low on direct human therapeutic evidence [12].

What it is: THCa is the acidic precursor of THC and may represent a large share of THC-related content in raw plant material. The key formulation issue is that THCa decarboxylates into THC during heating and can change during storage and processing [12].

Psychoactivity: THCa itself does not produce psychoactive effects associated with THC in humans, but this distinction only holds if the molecule stays acidic and is not substantially decarboxylated [12].

Research status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but these are not equivalent to established human outcomes [12].

Bottom line: THCa is best understood as a highly relevant precursor molecule whose interpretation depends heavily on route, temperature, processing, and storage. Any THCa claim must account for possible conversion into THC [12].

The legal significance for San Bernardino County: Our sublingual formula contains 1,500 mg THCa and only 90 mg delta-9 THC — well under the 0.3% Farm Bill threshold at point of sale. This means you can legally purchase, possess, and transport it throughout San Bernardino County and California. The THCa conversion happens at home, under your control. This is the most significant legal cannabis access innovation in history, backed by actual chemistry, not loopholes.

Delta-9 THC: The Most Studied Psychoactive Cannabinoid

Delta-9 THC has the strongest human evidence of the psychoactive cannabinoids, but also the clearest adverse-effect burden [1][13]-[15].

Institutionally best supported: NCCIH identifies THC-containing medicines as relevant to chemotherapy-related nausea/vomiting, appetite/weight loss in HIV/AIDS, and some multiple sclerosis and pain outcomes, while stressing many other uses remain uncertain [1].

Pain evidence: A 2022 systematic review found cannabis-based products with high THC content or comparable THC:CBD ratios may provide short-term pain benefit but increased dizziness, sedation, nausea, and treatment discontinuation due to adverse events [13].

Pharmacokinetics: Inhaled THC produces effects within seconds to minutes, peaks in 15-30 minutes, and tapers over a few hours. Oral THC has later onset, later peak, and longer duration — crucial for both benefit and overconsumption risk [14].

Mental health risk: A 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder, with concerning signals for anxiety and depression in nontherapeutic settings [15].

Broader safety: Institutional literature describes anxiety/panic at high doses, tachycardia, blood pressure changes, dependency potential, withdrawal, pregnancy concerns, accidental pediatric exposure, and vape-related lung injury [1][14][15].

Bottom line: Delta-9 THC has legitimate therapeutic relevance in some settings but carries the clearest intoxication, psychiatric, and dose-related safety liabilities in this document [1][13]-[15].

Why our formula uses only 90 mg delta-9 THC: We deliberately minimized delta-9 THC exposure while maximizing therapeutic potential through other cannabinoids. This reduces impairment risk while maintaining efficacy through the entourage effect.

CBN: The Sleep Cannabinoid (With Weak Evidence)

CBN has weak human evidence; marketing has clearly moved ahead of the data [12][16][17].

What it’s marketed for: Sleep and sedation. That reputation is widespread, but clinical support is far thinner than the market suggests [16][17].

Best direct review: A 2021 narrative review screened 99 human-study abstracts, reviewed eight full-text articles, and found no clinical trials using validated sleep questionnaires or formal polysomnography that could substantiate strong sleep-promoting claims for CBN [16].

Broader sleep literature: A 2024 updated review concluded that overall cannabinoid sleep research still doesn’t match real-world use scale, and the need for better-designed, adequately powered trials remains substantial [17].

Chemical context: THCa review notes THC can degrade toward CBN under certain conditions, explaining why CBN is often discussed in aging or oxidized cannabis chemistry contexts [12].

Bottom line: CBN is one of the clearest examples where cultural reputation is stronger than current clinical evidence [16][17].

Why we include 750 mg CBN: At 1-2 mL doses, our formula delivers 25-50 mg CBN — at or above the 20 mg threshold associated with reduced sleep disturbance in published research. We include it for its theoretical value while being honest about the evidence limits.

CBC: The Emerging Neurogenic Compound

CBC evidence is emerging, intriguing, and still overwhelmingly preclinical or review-based [18][19].

Pharmacology: A 2024 focused review argues CBC has distinct pharmacodynamics, pharmacokinetics, and receptor behavior relative to better-known cannabinoids, highlighting antinociceptive, antibacterial, and anti-seizure areas as especially interesting research targets [18].

Older literature: Review literature summarizing CBC in animal and in vitro work reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, and possible neurobiological or antiproliferative relevance, but these signals are not yet strong evidence for patient-facing claims [19].

Safety caveat: The 2024 CBC review explicitly notes that over-the-counter CBC products are already being sold despite little evidence establishing clinical efficacy or safety [18].

Bottom line: CBC belongs in the category of scientifically credible minor cannabinoids that deserve more research, not in the category of already-validated clinical actives [18][19].

Why we include 750 mg CBC: We believe in the neurogenic and anti-inflammatory potential based on preclinical data, while being transparent that human validation is still emerging.

The Terpene Profile: Aroma, Flavor, and Potential Bioactivity

Terpene claims need even stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. Robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene: Citrus-Bright

Evidence: Largely review and preclinical, with useful safety literature [20]-[22].

Potential activity: A 2021 review describes limonene as multifunctional with antioxidant, anti-inflammatory, cardioprotective, gastroprotective, and immune-modulatory possibilities, but most claims come from nonhuman or non-cannabis literature [21].

Safety note: Limonene oxidation products, especially hydroperoxides, are clinically relevant contact allergens important in patch-testing literature [22].

Bottom line: Limonene is biologically active and widely discussed, but cannabis-specific therapeutic claims should stay conservative unless directly supported in humans [20]-[22].

San Bernardino County connection: The bright citrus aroma may remind you of the orange groves that once dominated the Inland Empire, or the lemon trees still growing in old Ontario neighborhoods.

Myrcene: The Relaxation Terpene (With Limited Human Proof)

Evidence: Mostly preclinical, with very limited human evidence [20][23].

Research summary: A 2021 myrcene review describes anxiolytic, antioxidant, anti-inflammatory, and analgesic properties and discusses possible mechanisms, but explicitly states human studies are lacking [23].

Interpretation caution: Myrcene is often invoked as a proven human sedative that explains “couch-lock” or sleep effects. That claim is stronger than human evidence currently supports [20][23].

Bottom line: Myrcene is a plausible bioactive terpene, but compound-specific clinical claims about mood, pain, or sedation remain far ahead of definitive human proof [23].

Caryophyllene: The CB2 Agonist

Evidence: Among the most mechanistically interesting terpenes because of direct cannabinoid-system relevance, but still mostly preclinical [24].

Why it stands out: A 2021 focused review describes beta-caryophyllene as a selective CB2 receptor agonist — unusual and especially relevant when discussing cannabis terpenes pharmacologically rather than just aromatically [24].

Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, and gastroprotective actions are repeatedly discussed, but human clinical confirmation remains limited [24].

Bottom line: Beta-caryophyllene is arguably the strongest candidate for a terpene with cannabinoid-system significance, but it still should not be described as clinically proven for outcomes commonly attributed to it [24].

San Bernardino County connection: Beta-caryophyllene is the compound that gives black pepper its spiciness — a familiar kitchen staple across Inland Empire households.

Pinene: Forest-Fresh

Evidence: Promising preclinical literature, weak human clinical confirmation [20][25].

Brain-health framing: A 2021 review on pinene and linalool as terpene-based medicines for brain health found antioxidant, anti-inflammatory, and neuroprotective signals justifying future study, but emphasized well-designed clinical trials are lacking [25].

Interpretation caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC-related cognitive effects remain interesting hypotheses rather than settled clinical facts [20][25].

Bottom line: Pinene deserves scientific attention, but strong cognition-related claims should be presented as exploratory [25].

San Bernardino County connection: The piney aroma evokes the San Bernardino National Forest, the aroma of Jeffrey pines on a morning hike near Big Bear.

Linalool: Floral Lavender

Evidence: Similar to pinene — substantial preclinical interest, limited direct clinical confirmation [20][22][25][26].

Research summary: Linalool is repeatedly discussed in relation to stress, mood, and brain-health pharmacology. The 2021 brain-health review found enough preclinical signal to justify continued investigation in neurological and psychiatric contexts while emphasizing the lack of robust human trials [25].

Additional literature: Separate review literature discusses possible antidepressant mechanisms and neuropharmacologic relevance, but this remains translational rather than definitive [26].

Safety note: As with limonene, oxidized linalool hydroperoxides are recognized allergens in dermatitis literature [22].

Bottom line: Linalool is scientifically credible as a bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26].

Humulene: Earthy-Woody

Evidence: Translationally interesting, but still early [20][27].

Scoping-review findings: A 2024 scoping review analyzed 340 articles and found broad preclinical evidence for anti-inflammatory and other biologic effects, with some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27].

Interpretation caution: Those findings are valuable for hypothesis generation but do not yet establish consistent human efficacy across pain, inflammation, or mood outcomes [27].

Bottom line: Humulene is one of the more interesting terpene research targets in this list, but it remains far from clinically settled [27].

Terpinolene: Piney-Fruity-Sparkling

Evidence: One of the least clinically characterized terpenes in this file [20][28].

Systematic-review findings: A 2021 terpinolene review screened 2,449 records and included 57 studies, concluding that terpinolene has a range of reported biological effects but the evidence base is still dominated by in silico, in vitro, and animal studies rather than human trials [28].

Bottom line: Terpinolene is biologically interesting, but among listed terpenes it remains especially underdeveloped clinically [20][28].

RSO Sublingual Oil Formula: Complete Transparency

Cannabinoid	Amount	Evidence Tier
CBD	4,500 mg	Strong human data in specific indications
CBG	3,000 mg	Promising preclinical, limited human data
Delta-8 THC	6,000 mg	Pharmacologically relevant, less characterized
THCa	1,500 mg	Important chemically, emerging human data
Delta-9 THC	90 mg	Strong human data, clear safety profile
CBN	750 mg	Weak human evidence, marketing ahead of data
CBC	750 mg	Emerging preclinical, clinically immature
Total	16,590 mg	553 mg/mL

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier: Organic MCT oil
• Format: 30 mL bottle with graduated dropper (0.1 mL increments)
• Onset: 15-45 minutes (sublingual)
• Peak: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Doses: ~40-60 per bottle depending on serving size
• Price: $129.99

Why this price point matters for San Bernardino County: At 16,590 mg total cannabinoids, you’re paying $0.0078 per mg. Compare that to typical dispensary RSO in San Bernardino County at $0.02-0.05 per mg for single-cannabinoid products with no lab testing. Our price reflects multi-cannabinoid complexity, third-party testing, and the fact that we publish the recipe for free if you can’t afford it.

RSO Vape Cartridge Formula: Fast Breakthrough Relief

Cannabinoid	Percentage	mg per 1g Cartridge
CBD	30%	300 mg
CBG	20%	200 mg
Delta-8 THC	15%	150 mg
THCa	10%	100 mg (auto-decarbs when vaped)
CBN	10%	100 mg
CBC	10%	100 mg
Total	95%+	950+ mg

• Live Terpenes: 5%+
• Thread: 510 universal battery compatibility
• Onset: 1-2 minutes (fastest available)
• Peak: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35% (technique-dependent)
• Price: $49.99

When San Bernardino County residents should choose vape: For acute breakthrough pain during a flare-up, panic attacks in traffic on the 215 Freeway, nausea from chemo before an appointment at City of Hope in Duarte, or instant sleep support when you can’t wait 45 minutes.

Terpene Profile: Sensory Experience and Potential Synergy

Both products contain the same seven-terpene profile at 5% concentration:

Terpene	Aroma Profile	Potential Activity	Evidence Level
Limonene	Citrus-bright	Antioxidant, anti-inflammatory, mood	Preclinical/review
Myrcene	Herbal, musky	Anxiolytic, anti-inflammatory	Preclinical, weak human
Caryophyllene	Pepper/spice	CB2 agonist, anti-inflammatory	Preclinical, mechanistic
Pinene	Forest-fresh	Neuroprotective, alertness	Preclinical, weak human
Linalool	Floral, lavender	Stress, mood, calming	Preclinical, weak human
Humulene	Earthy, woody	Anti-inflammatory, cannabimimetic	Preclinical, emerging
Terpinolene	Piney, fruity, sparkling	Antioxidant, sedative	Preclinical, very weak human

For San Bernardino County residents: These aromas create a sensory experience that connects you to your environment — the citrus groves of old Ontario, the pine forests of Big Bear, the desert sage of Joshua Tree. While the clinical evidence remains limited, the preclinical signals and traditional use in aromatherapy suggest these terpenes contribute to the entourage effect.

Condition-Specific Usage Context for San Bernardino County

Critical Disclaimer: These contexts are informed by research cited in this document and our formulation rationale. They are NOT medical prescriptions, NOT FDA-approved treatment protocols, and NOT a substitute for professional medical care. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids. These products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.

Chemotherapy-Related Nausea and Appetite Support

Common scenario in San Bernardino County: You’re undergoing chemo at Kaiser Fontana, City of Hope in Duarte, or St. Bernardine Medical Center in San Bernardino. The nausea hits hard, and prescription antiemetics aren’t enough.

Protocol:

• Pre-chemo: 0.5-1.0 mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)

Evidence context: Delta-8 THC antiemetic evidence [9], delta-9 THC nausea/vomiting evidence [1][13], CBD anxiolytic buffering [3]

San Bernardino County-specific note: If you’re driving home to Rancho Cucamonga or Fontana after chemo, use the raw (non-decarboxylated) sublingual option to avoid impairment. The THCa provides anti-inflammatory benefits without psychoactivity.

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

Common scenario in San Bernardino County: You injured your back working in a warehouse in San Bernardino, developed fibromyalgia, or have arthritis from years of desert heat and physical labor.

Protocol:

• Daytime: 0.3-0.5 mL raw sublingual — provides anti-inflammatory cannabinoid exposure without psychoactive impairment (ideal for working at the Ontario Airport or driving for UPS in Fontana)
• Nighttime: 0.5-1.0 mL decarboxylated sublingual — combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset

Evidence context: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep Support

Common scenario in San Bernardino County: The desert heat keeps you up, PTSD from military service at Twentynine Palms Marine Base causes nightmares, or chronic pain interrupts sleep.

Protocol:

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL: Delivers 50 mg CBN — the dosage investigated in 2024 sleep literature
• At 1.0 mL: Delivers 25 mg CBN — above the 20 mg threshold associated with reduced sleep disturbance

Evidence context: CBN sleep evidence [16][17], cannabis and sleep review literature

San Bernardino County tip: The dry desert air can exacerbate sleep issues. Consider using a humidifier in your bedroom alongside the sublingual oil for optimal results.

Anxiety and Stress

Common scenario in San Bernardino County: You’re a veteran in Apple Valley with PTSD, a teacher in Redlands dealing with pandemic-related stress, or a commuter white-knuckling it through the Cajon Pass daily.

Protocol:

• Daytime functional relief: 0.3 mL raw sublingual — CBD and CBG address anxiety pathways without psychoactive impairment
• Nighttime: 1.0 mL sublingual — full cannabinoid profile including CBN for sleep architecture

Evidence context: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage-effect evidence [20]

General Titration Principle: Start Low, Go Slow

Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications (especially if you’re under care at Loma Linda VA or Kaiser), and other factors.

Delivery and Access for San Bernardino County

OilWell operates the only same-day RSO delivery system in Houston — but for San Bernardino County residents, we offer nationwide shipping that gets our products to your door in 2-3 business days via USPS Priority Mail.

Shipping to San Bernardino County

• All 50 states where Farm Bill-compliant products are legal
• USPS Priority Mail: 2-3 business days to any address in San Bernardino County (San Bernardino, Ontario, Rancho Cucamonga, Fontana, Redlands, Chino Hills, Upland, Montclair, Claremont, Yucaipa, Rialto, Colton, Highland, Grand Terrace, Loma Linda, and all unincorporated areas)
• FedEx and UPS Ground: 3-5 business days
• Discreet packaging: No cannabis branding visible
• Tracking provided for all orders
• Temperature-stable packaging for summer shipments (critical for San Bernardino County’s 100+°F days)
• Signature-required option available

Free shipping threshold: Orders over $150 ship free to San Bernardino County.

International Shipping from San Bernardino County Perspective

We ship internationally to jurisdictions with compatible hemp laws. The THCa legal framework makes this possible: because our product contains less than 0.3% delta-9 THC at point of sale, it meets the definition of a hemp-derived product under the 2018 Farm Bill.

• Full documentation included: Certificates of Analysis (COAs), receipts for customs
• Customer responsibility: You must verify legality in your jurisdiction and accept all customs/legal risk
• Shipping costs: Minimum flat fee; excessive costs billed to customer
• Contact: (832) 416-2816 or [email protected]

The significance for San Bernardino County families: If you have relatives in countries without legal cannabis access — perhaps family in Mexico, Canada, or Europe — you can legally ship them our products. Rick Simpson couldn’t ship his oil anywhere; it was Schedule I everywhere. We’ve completed a piece of his vision that prohibition made impossible.

How to Order from San Bernardino County

1. Visit OilWellCBD.com
2. Select RSO Sublingual Oil ($129.99) or RSO Vape Cartridge ($49.99)
3. Enter your San Bernardino County shipping address
4. Choose shipping method (USPS Priority recommended for 2-3 day delivery)
5. Complete age verification (21+ required)
6. Receive tracking info within 24 hours
7. Product arrives in discreet packaging

Phone orders: (832) 416-2816 (Monday-Thursday 10 AM-7 PM, Friday-Saturday 10 AM-10 PM, Sunday 10 AM-4 PM Central Time)

Email: [email protected]

Local Pickup Option for San Bernardino County Visitors

If you’re traveling to Houston for treatment at MD Anderson or any Texas Medical Center institution, we offer free same-day delivery to your hotel or the hospital. Many San Bernardino County cancer patients travel to Houston for specialized care — we can deliver directly to you there.

Safety and Legal Compliance for San Bernardino County

Age Requirements

You must be 21 years or older to purchase RSO products. We verify age at checkout.

THC Content Compliance

Our RSO Sublingual Oil contains only 90 mg delta-9 THC in the entire 30 mL bottle (3 mg/mL) — well under the 0.3% federal limit. All cannabinoids are hemp-derived. The product is legal under federal law and in California.

Important for San Bernardino County residents: California law allows adults 21+ to possess and use hemp-derived products with less than 0.3% delta-9 THC. You can legally keep our products in your home in Rancho Cucamonga, carry them while hiking in the San Bernardino National Forest, or transport them through the Cajon Pass.

Customer Responsibility for THCa Conversion

THCa converts to delta-9 THC when heated. You are responsible for understanding and complying with local laws regarding cannabinoid products. We ship with full documentation, COAs, and receipts. International customers accept all customs and legal responsibility.

For San Bernardino County: If you choose to decarboxylate our product at home in Fontana or Ontario, you are converting it to a higher-THC form. While possession remains legal under California’s Prop 64 for adults 21+, be aware that driving under the influence remains illegal. Do not operate vehicles or machinery after consuming activated product.

FDA Disclaimers

These products have not been evaluated by the Food and Drug Administration. They are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Consult a healthcare provider before use, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns.

Safety Warnings

• May cause drowsiness or impairment
• Do not operate vehicles or machinery while under the influence
• Keep out of reach of children and pets
• Store in a cool, dry place away from direct sunlight (especially important in San Bernardino County’s desert heat)
• Consult physician if pregnant or nursing
• Discuss with your doctor if taking other medications (especially at facilities like Kaiser Fontana or Loma Linda VA)

Legal Notice

Buyer is responsible for checking local laws. We assume no legal responsibility for customer’s use or decarboxylation decisions. Void where prohibited by law. The product is legal at point of sale; activation choices are customer-controlled and customer-responsible.

Why San Bernardino County Residents Choose OilWell RSO

You need multi-cannabinoid support: Many San Bernardino County residents face complex health challenges. A veteran in Twentynine Palms with PTSD, chronic pain, and insomnia needs more than single-cannabinoid CBD. Our seven-cannabinoid formula addresses multiple pathways simultaneously.

You want control over psychoactivity: Whether you’re working a shift at the Ontario Airport, driving kids to school in Chino Hills, or operating equipment in San Bernardino’s logistics industry, you need the option of non-psychoactive use. Our raw THCa option gives you that.

You’ve been failed by pharmaceuticals: If you’re tapering off benzos under medical supervision in Redlands, if opioids from a work injury in Fontana stopped working, if the VA in Loma Linda has limited options — our story resonates. Colin quit Xanax cold turkey using this knowledge. He lived what you’re living.

You demand transparency: In a market flooded with untested products claiming to be “RSO,” we publish every milligram. If you can’t afford $129.99, you can source the ingredients and make it yourself using our published formula. That’s the Rick Simpson ethos adapted for 2024.

You value evidence over hype: Every claim in this document is tied to peer-reviewed research. We tell you what’s proven, what’s emerging, and what’s overstated. That honesty is what builds trust with informed consumers in San Bernardino County’s educated communities.

You need reliable access: Whether you live in the urban core of San Bernardino or the remote stretches of the High Desert, we ship to your door in 2-3 days. No medical card required. No driving to a dispensary required. No wondering if the product is real.

The Bottom Line for San Bernardino County

Rick Simpson started a movement based on personal testimony and a belief that cannabis oil could help people when conventional medicine failed. He gave his oil away for free and taught others to make it. He operated illegally, used dangerous solvents, made unverified cure claims, and had no scientific training — but his core intuition was right: cannabinoids matter.

OilWell Cannabis evolved that intuition into something San Bernardino County residents can trust: a multi-cannabinoid, terpene-enhanced, lab-tested, solvent-free formula that you can legally purchase, possess, and use throughout the Inland Empire. We publish our complete recipe. We ship to your door. We base every claim on peer-reviewed science. And we put the potency decision entirely in your hands.

Whether you’re in San Bernardino, Ontario, Rancho Cucamonga, Fontana, Redlands, or any of the unincorporated communities stretching to the Nevada border, you now have access to the most thoughtfully formulated RSO available — without leaving your home.

Ready to try it? Order now at OilWellCBD.com or call (832) 416-2816. We ship to all of San Bernardino County, and we’re here to answer your questions.

References

RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.

RS2. Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005.

RS3. Simpson R. Instructions and dosing information published on phoenixtears.ca.

RS4. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436-444.

RS5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203.

RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ) — Health Professional Version. NIH/NCI. Updated 2024.

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH.

2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238.

3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049.

4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438.

5. Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229.

6. Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752.

7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212.

8. Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471.

9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933.

10. LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028.

11. Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249.

12. Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130.

13. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153.

14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360.

15. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440.

16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371.

17. Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727.

18. Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213.

19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364.

20. André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543.

21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566.

22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12.

23. Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666.

24. Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639.

25. Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211.

26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092.

27. Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674.

28. Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768.

29. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364.